FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.13 | FHIR Version n/a User: [n/a]

716125002: Pembrolizumab (substance)

Status: current, Primitive. Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3304810011 Pembrolizumab (substance) en Fully specified name Active Case insensitive SNOMED CT core

3304811010 Pembrolizumab en Synonym Active Case insensitive SNOMED CT core

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pembrolizumab	Is a	Programmed cell death protein 1 inhibitor	true	Inferred relationship	Some
Pembrolizumab	Has disposition	Programmed cell death protein 1 inhibitor	true	Inferred relationship	Some
Pembrolizumab	Is a	Antineoplastic agent	true	Inferred relationship	Some
Pembrolizumab	Is a	Monoclonal antibody agent	false	Inferred relationship	Some
Pembrolizumab	Is a	Monoclonal antibody	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Pembrolizumab only product	Has active ingredient	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab only product in parenteral dose form	Has active ingredient	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab 50 mg powder for solution for injection vial	Has precise active ingredient	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab 50 mg powder for solution for injection vial	Has BoSS	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab 25 mg/mL solution for injection	Has precise active ingredient	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab 25 mg/mL solution for injection	Has BoSS	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab-containing product	Has active ingredient	True	Pembrolizumab	Inferred relationship	Some	1
Pembrolizumab-containing product in parenteral dose form	Has active ingredient	True	Pembrolizumab	Inferred relationship	Some	1

Reference Sets

Substance foundation reference set